To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Last viewed
- Genaissance Obtains License to Vanderbilt Patent Linking Genetics to Key Drug Safety Issue
- ThromboGenics Begins Phase III Program with Microplasmin for the Non-surgical Treatment of Back of the Eye Disease - ThromboGenics’ lead product to be studied in the treatment of vitreomacular adhesion in the US and Europe
- Molekularer Mechanismus in der Tumorentstehung aufgeklärt
- How a SARS-CoV-2 infection can become severe COVID-19 - Severity is linked to disruption of the endothelial barrier and can be measured by looking at inflammatory and endothelial plasma proteins
- Fesoterodine approved in the U.S. - UCB entitled to receive milestone payment and royalties from Pfizer
